Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

STF-31

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
The synthetic compound fasentin has been described as a modulator of GLUT-1 and GLUT-4 transporters, thus inhibiting glucose… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
2019
2019
ABSTRACT Nanomedicine modification with ligands directed to receptors on tumor blood vessels has the potential for selectively… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
2018
2018
BackgroundTargeting glucose metabolism is a promising way to interfere with tumor cell proliferation and survival. However… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
2016
2016
While environmental exposures are not the single cause of Parkinson’s disease (PD), their interaction with genetic alterations is… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2015
2015
The tumorigenic potential of human pluripotent stem cells (hPSCs) is a major limitation to the widespread use of hPSC derivatives… Expand
2014
2014
The small-molecule probes STF-31 and its analogue compound 146 were discovered while searching for compounds that kill VHL… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2013
2013
Abstract : This project is aimed at test the hypothesis that targeting androgen receptor (AR) expression by small-molecule agents… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 5
  • figure 6
Highly Cited
2011
Highly Cited
2011
A screen identifies a drug that specifically kills glycolysis-dependent cancer cells by inhibiting glucose uptake. Cancer’s… Expand
2011
2011
known as synthetic lethal screening involves targeting tumour cells containing particular mutations with small molecules that are… Expand